The US Food and Drug Administration (FDA) halts the use of blood plasma from recovered Covid-19 patients to treat the other infected people.
Amar Jesani, editor of the Indian Journal of Medical Ethics, said that the therapeutic effectivity of the therapy has to be established through clinical research. “So far there is no evidence providing that evidence,” he told ET.
“There are many recommendations by ICMR that are based either on hope or the premise that even if it doesn’t work it does no harm. However, the correct approach is to test the hypothesis and if it is proven that it doesn’t work they should be brave enough to reverse the recourse,” said an epidemiologist.
The analysis of the plasma therapy by the Indian Council Of Medical Research (ICMR) is still in progress and will be shared on its completion, a senior official of the ICMR said.